Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HARRYS ANTONIO TORRES and AHMED KASEB.
HARRYS ANTONIO TORRES
Connection Strength
3.087
AHMED KASEB
  1. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol. 2016 10; 65(4):862-864.
    View in: PubMed
    Score: 0.553
  2. Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol. 2013 Jun 27; 5(6):332-5.
    View in: PubMed
    Score: 0.451
  3. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 09 01; 118(9):1609-1617.
    View in: PubMed
    Score: 0.225
  4. Virologic Impact of Radiotherapy in Hepatitis C Virus-Infected Patients With Hepatocellular Carcinoma. Hepatology. 2020 08; 72(2):775-777.
    View in: PubMed
    Score: 0.185
  5. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
    View in: PubMed
    Score: 0.181
  6. Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 02; 114(2):250-257.
    View in: PubMed
    Score: 0.166
  7. Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study. Clin Infect Dis. 2018 10 30; 67(10):1635-1636.
    View in: PubMed
    Score: 0.163
  8. Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer. J Hepatocell Carcinoma. 2018; 5:81-86.
    View in: PubMed
    Score: 0.161
  9. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017 Sep; 67(5):411-431.
    View in: PubMed
    Score: 0.149
  10. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799.
    View in: PubMed
    Score: 0.148
  11. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Aliment Pharmacol Ther. 2016 12; 44(11-12):1235-1241.
    View in: PubMed
    Score: 0.142
  12. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50.
    View in: PubMed
    Score: 0.125
  13. Hepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infection. Dig Liver Dis. 2015 Apr; 47(4):348-9.
    View in: PubMed
    Score: 0.125
  14. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series. J Hepatocell Carcinoma. 2014; 1:109-14.
    View in: PubMed
    Score: 0.121
  15. The effect of transcatheter arterial chemoembolization on hepatitis C viremia. Oncologist. 2012; 17(9):e21-3.
    View in: PubMed
    Score: 0.102
  16. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. Oncologist. 2023 08 03; 28(8):714-721.
    View in: PubMed
    Score: 0.057
  17. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.